Lymphoid Leukemia — Trials

Lymphoid Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

3,262 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 827
Recruiting: 464
Ph III recruiting: 43
Growth YoY: −9.1%
Industry share: 18%
Top sponsor: City of Hope Medical Center
Termination share: 33.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (489)

clinicaltrialsPublishedShowing 51–100 of 127 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02094794	Total Marrow and Lymphoid Irradiation and Chemotherapy Before DSCT in Treating Patients With High-Risk ALL or AML	active not recruiting	Phase 2	108	City of Hope Medical CenterOTHER	1	Jul 1, 2026	clinicaltrials
NCT02339922	Ixazomib Citrate and Rituximab in Treating Patients With Indolent B-cell Non-Hodgkin Lymphoma	active not recruiting	Phase 2	33	University of WashingtonOTHER	1	Jul 1, 2026	clinicaltrials